middle.news
LTR Pharma Advances US Launch with SPONTAN Phase II Data and ROXUS Agreements
9:01am on Tuesday 28th of July, 2026 AEST
•
Pharmaceuticals
Read Story
LTR Pharma Advances US Launch with SPONTAN Phase II Data and ROXUS Agreements
9:01am on Tuesday 28th of July, 2026 AEST
Key Points
SPONTAN Phase II interim data confirms 10-minute median Tmax
Definitive US commercial agreements signed for ROXUS telehealth and pharmacy
OROFLOW intranasal study gains ethics approval for oesophageal motility disorders
Strong cash position of A$19.6 million with no debt at June 2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Ltr Pharma (ASX:LTP)
OPEN ARTICLE